Systemic sclerosis is a complex autoimmune condition marked by aberrant immune activation, widespread fibrosis and vasculopathy that affect the skin and multiple internal organs. The disease manifests ...
Diffuse cutaneous systemic sclerosis ("dcSSc") is a rare, progressive autoimmune disease characterized by immune activation, vasculopathy and fibrosis affecting the skin and internal organs, including ...
Please provide your email address to receive an email when new articles are posted on . Nearly 10% of patients with systemic sclerosis had systemic sclerosis sine scleroderma, a subtype without skin ...
The prevalence of SSc among Alaska Native and American Indian adults is comparable to or higher than other populations, with high GI and pulmonary involvement.
RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Proximal weakness and elevated creatine kinase were ...
GlobalData on MSN
Aisa Pharma reports positive results for AISA-021
The study included 64 patients and was conducted in two segments.
A nationwide Swedish register-based study revealed that individuals with systemic sclerosis had a higher risk for hematologic malignancies. Myeloid malignancies typically presented around disease ...
Although less common than other subtypes of systemic sclerosis (SSc), systemic sclerosis sine scleroderma (ssSSc) makes up more than 8% of SSc cases and "should not be neglected," according to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results